Related Experiment Video

Updated: Jul 9, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Heart transplantation in patients with Emery-Dreifuss muscular dystrophy: case reports

A Dell'Amore1, L Botta, S Martin Suarez

  • 1Heart and Lung Transplantation Program, S. Orsola-Malpighi University of Bologna, Bologna, Italy. dellamore76@libero.it

Transplantation Proceedings
|December 20, 2007
PubMed

Insights

Emery-Dreifuss muscular dystrophy (EDMD) is a genetic condition causing progressive muscle weakness and heart problems. This study reports on two EDMD patients successfully treated with heart transplantation for end-stage cardiomyopathy.

Area of Science:

  • Cardiology
  • Genetics
  • Neuromuscular Disorders

Background:

  • Emery-Dreifuss muscular dystrophy (EDMD) is a rare inherited neuromuscular disorder.
  • EDMD is characterized by progressive muscle weakness, contractures, and cardiac conduction defects.
  • Cardiac involvement is a major cause of morbidity and mortality in EDMD patients.

Observation:

  • Few cases of cardiac transplantation have been documented for muscular dystrophy.
  • Only four instances of heart transplantation for end-stage EDMD cardiomyopathy exist in literature.
  • This report details the experience with two consecutive EDMD patients undergoing heart transplantation.

Findings:

  • Successful heart transplantation was performed in two consecutive patients with EDMD.
  • Both patients received cardiac transplants for end-stage EDMD-related cardiomyopathy.
  • The study highlights the feasibility of heart transplantation in managing advanced EDMD cardiac complications.

Implications:

  • Heart transplantation may be a viable therapeutic option for select EDMD patients with end-stage cardiac disease.
  • This experience expands the limited data on cardiac transplantation outcomes in EDMD.
  • Further research is warranted to establish long-term efficacy and patient selection criteria for heart transplantation in EDMD.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development08:07

Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development

Published on: July 1, 2020

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...